NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyInvestigator Initiated Multi-Site Clinical Trials (R01)
About This Grant
-Purpose. The purpose of this Funding Opportunity Announcement is to provide a vehicle for submitting grant applications for investigator-initiated multi-site Phase II or Phase III randomized, controlled clinical trials. The trials may address any research question related to the mission and goals of NHLBI and may test clinical or behavioral interventions. Investigators should consult the NHLBI s Guidelines for Investigator Initiated Clinical Trials (http://www.nhlbi.nih.gov/funding/policies/clinical.htm) for more detailed instructions and information about multi-site clinical trial grant applications. Additional information about the mission, strategic plan and research interests of the NHLBI can be found at NHLBI s website (http://www.nhlbi.nih.gov/index.htm). -This Funding Opportunity Announcement is not intended for support of single-center studies or multi-center observational studies that are not testing an intervention. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Awards may be converted by NHLBI to cooperative agreements (U01).
Grant Summary
Investigator Initiated Multi-Site Clinical Trials (R01) is a National Institutes of Health grant providing funding that varies by award for municipality. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $0K
Rolling / Open
- 1Confirm your organization is eligible for Investigator Initiated Multi-Site Clinical Trials (R01) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Investigator Initiated Multi-Site Clinical Trials (R01): Frequently Asked Questions
Who is eligible for the Investigator Initiated Multi-Site Clinical Trials (R01)?
Investigator Initiated Multi-Site Clinical Trials (R01) is offered by National Institutes of Health and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Investigator Initiated Multi-Site Clinical Trials (R01) provide?
Investigator Initiated Multi-Site Clinical Trials (R01) provides an amount that varies by award per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Investigator Initiated Multi-Site Clinical Trials (R01) deadline?
Investigator Initiated Multi-Site Clinical Trials (R01) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, National Institutes of Health, before you apply, and submit as early as possible because rolling programs can close once funds are committed.
How do you apply for the Investigator Initiated Multi-Site Clinical Trials (R01)?
To apply for Investigator Initiated Multi-Site Clinical Trials (R01), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.